I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 41 350 VND -0.12% Market Closed
Market Cap: 6.4T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Net Margin
Imexpharm Corp

11.4%
Current
13%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.4%
=
Net Income
247.2B
/
Revenue
2.2T

Net Margin Across Competitors

Country VN
Market Cap 6.4T VND
Net Margin
11%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

Imexpharm Corp
Glance View

Market Cap
6.4T VND
Industry
Pharmaceuticals

Imexpharm Corp. engages in the manufacture, import, export and trade of pharmaceuticals, medicinal chemicals and botanical. The company is headquartered in Cao Lanh, Dong Thap and currently employs 1,356 full-time employees. The company went IPO on 2006-12-04. The firm manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. The company is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.

IMP Intrinsic Value
27 964.22 VND
Overvaluation 32%
Intrinsic Value
Price
I

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.4%
=
Net Income
247.2B
/
Revenue
2.2T
What is the Net Margin of Imexpharm Corp?

Based on Imexpharm Corp's most recent financial statements, the company has Net Margin of 11.4%.